Recall Z-0602-2026

BioFire Diagnostics, LLC · initiated October 22, 2025

Class II Open, Classified

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)

Codes / lots: UDI: 00815381020529 /Lot # 2649724 Expanded Lot#: 1471725

Reason for recall

Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures.

FDA-determined cause: Under Investigation by firm

Action taken

On May 28, 2026, Biomerieux issued a "Urgent: Medical Device Recall" Expansion Notification to affected consignees via E-Mail. Initial notification was sent out on October 22, 2025. Biomerieux asked consignees to take the following actions: 1. Examine your inventory for the lot identified in this field safety notice. 2. Discontinue use and discard any remaining product from this lot in your possession. 3. Please confirm the quantity of kits that have been destroyed, previously used, or returned on the attached Acknowledgement of Receipt Form. 4. If you have further distributed this product, please identify any recipients and notify them at once. 5. Please complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification. 6. Complete and submit the report online. Regular Mail or Fax: Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form or submit by fax to 1-800-FDA-0178.

Details

Recall number
Z-0602-2026
Initiated
October 22, 2025
Posted by FDA
November 26, 2025
Product code
QOF – Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Quantity
97 Kits (2,910 pouches)
Distribution
US:AZ, FL,GA,ID NC, NH, NJ, NY, OR, PA, SC OUS: None
Recalling firm
BioFire Diagnostics, LLC, Salt Lake City, UT

Official FDA recall record